LakeShore Biopharma Co (LakeShore Biopharma Co) Beginning Cash Position : $50.75 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Beginning Cash Position?

LakeShore Biopharma Co's Beginning Cash Position for the quarter that ended in Sep. 2023 was $50.75 Mil.

LakeShore Biopharma Co's quarterly Beginning Cash Position declined from Sep. 2022 ($38.62 Mil) to Mar. 2023 ($0.00 Mil) but then increased from Mar. 2023 ($0.00 Mil) to Sep. 2023 ($50.75 Mil).

LakeShore Biopharma Co's annual Beginning Cash Position increased from Mar. 2021 ($0.31 Mil) to Mar. 2022 ($61.54 Mil) but then declined from Mar. 2022 ($61.54 Mil) to Mar. 2023 ($39.34 Mil).

LakeShore Biopharma Co Beginning Cash Position Historical Data

The historical data trend for LakeShore Biopharma Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Beginning Cash Position Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Beginning Cash Position

0.31

61.54

39.34

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Beginning Cash Position	Get a 7-Day Free Trial			60.48	7.80	38.62	-	50.75

LakeShore Biopharma Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

LakeShore Biopharma Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.